LTRN logo

Lantern Pharma (LTRN) Company Overview

Profile

Full Name:

Lantern Pharma Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 11, 2020

Indexes:

Not included

Description:

Lantern Pharma is a biotechnology company focused on developing targeted cancer therapies. They use advanced data analytics and artificial intelligence to identify and create treatments for specific cancer types, aiming to improve patient outcomes and reduce side effects. Their innovative approach seeks to personalize cancer care.

Events Calendar

Earnings

Next earnings date:

Mar 18, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Apr 25, 24 HC Wainwright & Co.
Neutral
Aug 10, 23 EF Hutton
Buy
Jun 26, 23 EF Hutton
Buy
May 18, 23 HC Wainwright & Co.
Neutral
Mar 21, 23 EF Hutton
Buy
Feb 15, 23 EF Hutton
Buy
Nov 1, 22 EF Hutton
Buy
Mar 11, 22 HC Wainwright & Co.
Buy
Nov 2, 21 HC Wainwright & Co.
Buy
Oct 7, 21 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Lantern Pharma?
  • Does Lantern Pharma pay dividends?
  • What sector is Lantern Pharma in?
  • What industry is Lantern Pharma in?
  • What country is Lantern Pharma based in?
  • When did Lantern Pharma go public?
  • Is Lantern Pharma in the S&P 500?
  • Is Lantern Pharma in the NASDAQ 100?
  • Is Lantern Pharma in the Dow Jones?
  • When was Lantern Pharma's last earnings report?
  • When does Lantern Pharma report earnings?
  • Should I buy Lantern Pharma stock now?

What is the ticker symbol for Lantern Pharma?

The ticker symbol for Lantern Pharma is NASDAQ:LTRN

Does Lantern Pharma pay dividends?

No, Lantern Pharma does not pay dividends

What sector is Lantern Pharma in?

Lantern Pharma is in the Healthcare sector

What industry is Lantern Pharma in?

Lantern Pharma is in the Biotechnology industry

What country is Lantern Pharma based in?

Lantern Pharma is headquartered in United States

When did Lantern Pharma go public?

Lantern Pharma's initial public offering (IPO) was on June 11, 2020

Is Lantern Pharma in the S&P 500?

No, Lantern Pharma is not included in the S&P 500 index

Is Lantern Pharma in the NASDAQ 100?

No, Lantern Pharma is not included in the NASDAQ 100 index

Is Lantern Pharma in the Dow Jones?

No, Lantern Pharma is not included in the Dow Jones index

When was Lantern Pharma's last earnings report?

Lantern Pharma's most recent earnings report was on Nov 7, 2024

When does Lantern Pharma report earnings?

The next expected earnings date for Lantern Pharma is Mar 18, 2025

Should I buy Lantern Pharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions